What does CUSIP G3141W106 represent in this 13F holders report?

CUSIP G3141W106 is the security identifier for EUCR - EUCRATES BIOMEDICAL ACQU COR - SHS used to aggregate holder disclosures.

How many institutions held EUCR - EUCRATES BIOMEDICAL ACQU COR - SHS in Q4 2022?

5 institutional investors reported EUCR - EUCRATES BIOMEDICAL ACQU COR - SHS for Q4 2022. Use the holders table for investor-level position and value details.

EUCRATES BIOMEDICAL ACQU COR - SHS (EUCR)

CUSIP: G3141W106

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class: Equity / SHS
Total 13F shares: 297,836
Share change: -8,033,837
Total reported value: $2,975,806
Price per share: $9.99
Number of holders: 5
Value change: -$80,526,646
Number of buys: 1
Number of sells: 34

Quarterly Holders Quick Answers

What is CUSIP G3141W106?
CUSIP G3141W106 identifies EUCR - EUCRATES BIOMEDICAL ACQU COR - SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2023
Previous quarter: Q3 2022

Recent filing periods for CUSIP G3141W106:

Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021

Institutional Holders of EUCRATES BIOMEDICAL ACQU COR - SHS (EUCR) as of Q4 2022

As of 31 Dec 2022, EUCRATES BIOMEDICAL ACQU COR - SHS (EUCR) was held by 5 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 297,836 shares. The largest 5 holders included EcoR1 Capital, LLC, SkyView Investment Advisors, LLC, DEUTSCHE BANK AG\, UBS Group AG, and Tower Research Capital LLC (TRC). This page lists 5 institutional shareholders reporting positions in this security for the Q4 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.